NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2021 pay jumps 67% to $1.9M
NEUROONE MEDICAL TECHNOLOGIES Corp reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
NEUROONE MEDICAL TECHNOLOGIES Corp reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, three executives at NEUROONE MEDICAL TECHNOLOGIES Corp received on average a compensation package of $928K, a 65% increase compared to previous year.
Average pay of disclosed executives at NEUROONE MEDICAL TECHNOLOGIES Corp
Dave Rosa, Chief Executive Officer, received $1.9M in total, which increased by 67% compared to 2020. 68% of Rosa's compensation, or $1.3M, was in option awards. Rosa also received $193K in non-equity incentive plan and $411K in salary.
Ron McClurg, Chief Financial Officer, received a compensation package of $523K. 56% of the compensation package, or $290K, was in option awards.
Steve Mertens, Chief Technology Officer, earned $371K in 2021, a 28% increase compared to previous year.
NEUROONE MEDICAL TECHNOLOGIES Corp's fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on April 29, 2022.